Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Ulixacaltamide in Adults With Essential Tremor
NCT06087276Phase 3Recruiting
- Sponsor
- Praxis Precision Medicines
- Start
- Nov 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ulixacaltamide, sponsored by Praxis Precision Medicines. Started Nov 2023; status: recruiting.
02
Drugs
ulixacaltamide
Beyond the preview
Go deeper on NCT06087276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087276.